Form4insider filings, from the source

SEC Form 4 · accession 0001181431-15-008494

SUPERNUS PHARMACEUTICALS, INC. · SUPN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 17, 2015
Accepted (ET)
Jun 19, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF3,F2Jun 17, 2015S63,085$16.6728D48,796ISee Note 2
Common StockF4,F2Jun 17, 2015S48,796$16.0218D0ISee Note 2
Common StockF1holding———7,641,250ISee Note 1

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses